ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NITE Nightstar Therapeutics Plc ADS

25.41
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nightstar Therapeutics Plc ADS NASDAQ:NITE NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 25.41 18.50 25.41 0 01:00:00

Knight To Host Electrifying Transportation Conference for Institutional Investors September 23rd in New York

09/09/2009 3:30pm

PR Newswire (US)


Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Nightstar Therapeutics Plc ADS Charts.
JERSEY CITY, N.J., Sept. 9 /PRNewswire-FirstCall/ -- Knight Capital Group, Inc. (NASDAQ:NITE) will host a one-day conference titled Electrifying Transportation for institutional investors on September 23, 2009 in New York. The conference will bring together thought leaders for a discussion on the technology, business models, and policy actions required to effect a paradigm shift for the automotive industry. The keynote address will be given by Jon Wellinghoff, Chairman of the Federal Energy Regulatory Commission. Additional speakers will include David Sandalow, Assistant Secretary for Policy and International Affairs at the U.S. Department of Energy, and James Woolsey, Venture Partner and VantagePoint Venture Partners and former Director of Central Intelligence Agency. The schedule of speakers for the Electrifying Transportation conference is available at: http://www.knight.com/invites/electricTrans/agenda/agenda8.20d.html. Institutional investors interested in attending the conference should call 212.479.2300 or email . Knight will host the conference at the New York Society of Securities Analysts (NYSSA), located at 1171 Avenue of the Americas, 2nd floor, New York, NY 10036, phone 212.541.4530. About Knight Knight Capital Group, Inc. (NASDAQ:NITE) is global capital markets firm that provides market access and trade execution services across multiple asset classes to buy- and sell-side firms. Knight's hybrid market model features complementary electronic and voice trade execution services in global equities and fixed income as well as foreign exchange, futures and options. The firm is consistently ranked as the leading source of off-exchange liquidity in U.S. equities. Knight also provides capital markets services to corporate issuers. Knight is headquartered in Jersey City, NJ with a growing global presence across North America, Europe and the Asia-Pacific region. For more information, please go to http://www.knight.com/. Certain statements contained herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are not historical facts and are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management, many of which, by their nature, are inherently uncertain and beyond our control. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict including, without limitation, risks associated with the costs, integration, performance and operation of businesses recently acquired, or that may be acquired in the future, by the Company and risks related to the costs and expenses associated with the Company's exit from the Asset Management business. Since such statements involve risks and uncertainties, the actual results and performance of the Company may turn out to be materially different from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made herein. Readers should carefully review the risks and uncertainties disclosed in the Company's reports with the U.S. Securities and Exchange Commission (SEC), including, without limitation, those detailed under the headings "Certain Factors Affecting Results of Operations" and "Risk Factors" in the Company's Annual Report on Form 10-K for the year-ended December 31, 2008, and in other reports or documents the Company files with, or furnishes to, the SEC from time to time. This information should also be read in conjunction with the Company's Consolidated Financial Statements and the Notes thereto contained in the Company's Annual Report on Form 10-K for the year-ended December 31, 2008, and in other reports or documents the Company files with, or furnishes to, the SEC from time to time. DATASOURCE: Knight Capital Group, Inc. CONTACT: Margaret Wyrwas, Senior Managing Director, Communications, Marketing & Investor Relations, Knight Capital Group, Inc., +1-201-557-6954, , or Kara Fitzsimmons, Director, Media Relations, Knight Capital Group, Inc., +1-201-356-1523, , or Jonathan Mairs, Vice President, Corporate Communications, Knight Capital Group, Inc., +1-201-356-1529, Web Site: http://www.knight.com/

Copyright

1 Year Nightstar Therapeutics Plc ADS Chart

1 Year Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart

1 Month Nightstar Therapeutics Plc ADS Chart